Stay updated on Inclisiran for CV Event Prevention in Established Disease Clinical Trial
Sign up to get notified when there's something new on the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page.

Latest updates to the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.0 was added to the record history, and the v3.4.3 entry was removed. This updates the visible version history for the study record.SummaryDifference0.1%

- Check9 days agoChange DetectedThe record history now includes a new revision entry (v3.4.3) and removes the older entry (v3.4.2).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 is now listed as the current entry, replacing Revision: v3.4.1 in the record history. This update does not affect study content or user-facing features.SummaryDifference0.5%

- Check44 days agoChange DetectedA funding notice banner was added and the record history shows a new revision (v3.4.1) with updates to Contacts/Locations and Study Status; the prior revision (v3.4.0) was removed.SummaryDifference0.9%

- Check51 days agoChange DetectedThe update adds a glossary toggle and color-codes changes (green for additions, red for deletions) and removes the older No FEAR Act Data and previous revision label; the fundamental history content remains the same.SummaryDifference0.7%

- Check65 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed; this is a minor admin update that does not change study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Inclisiran for CV Event Prevention in Established Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page.